Search

Monitoring Floating Marine Macro Litter (FMML) is a global priority, stressed within international programs, and regulated for the European Seas by the Marine Strategy Framework Directive. Although some well-defined common protocols exist for the assessment of beach litter and ingested litter, methodologies for FMML monitoring still vary, leading to some inconsistent results and hampering the global assessment of this threat. Within the MEDSEALITTER project (2016-2019), field experiments were implemented to define optimal monitoring parameters for FMML visual monitoring at different spatial scales, by assessing the influence of platform speed, strip width, observers experience, weather conditions, and litter size on its detectability. Along with the results of these experiments, we present the FMML density ranges detected across the over 20,000 km surveyed, highlighting a decreasing gradient from river mouths to coastal areas and the open sea, and providing a valuable contribution to the assessment of FMML in the Mediterranean Sea., (Copyright © 2020 Elsevier Ltd. All rights reserved.)

Information regarding the growth and development of endometriomas during IVF-intracytoplasmic sperm injection (ICSI) cycles is lacking. In this study, the aim was to estimate the influence of IVF-ICSI on the dimension of these cysts and to assess whether this treatment contributes to the manifestation of new endometriomas in patients already affected. Women were eligible if they had been diagnosed with ovarian endometrioma(s). Recruited patients who failed to become pregnant were scanned again 3-6 months later to evaluate the modification of the dimension of the cysts and/or the manifestation of new endometriomas. Forty-eight women completed the study protocol. The median (interquartile range) values for the volume of the cysts before and after the IVF-ICSI cycle were 3.9 (2.9-7.9) ml and 4.9 (2.4-9.9) ml, respectively (Wilcoxon rank test for paired data, not significant). The development of a new endometrioma was documented in one case (2.1%, 95% confidence interval 0.1-11.1%). Fear about the growth of ovarian endometriomas in women who have to undergo IVF-ICSI is not justified.